Insights

ZS Oncology Value Watchdog Report: Oncology Care Model

Christina Corridon

 


> Download

Oncology Care Model (OCM) is an experiment between the Centers for Medicare and Medicaid Services and commercial payers intended to drive the healthcare system towards value-based cancer care. Running from 2016 to 2021, this model incentivizes quality improvement and cost reduction through episode-based payment and performance-based payment. The model is regarded highly among providers; the number of voluntary participants was double the program’s expectation. This report provides insights on the expected impact on OCM participating practices, characterizes those practices, and discusses implications for manufacturers.


About the Expert





Christina Corridon is a Manager in the Boston office and a leader in the ZS Oncology Practice. She has over a decade experience working in the pharmaceutical and biotech industries, with specific expertise in oncology and biosimilars. During her consulting career she has worked on US and global projects spanning commercialization strategy including launch strategy and planning, go-to market strategy, commercial models, marketing strategy and brand planning. Christina has an MPH in Health Policy and Management from the UCLA Fielding School of Public Health and an MBA from the Stern School of Business at New York University focused in Marketing. Christina completed her BA at Cornell University.                 

Contact ZS